For example, studies have shown that increased expression of CD38 helps prostate cancer cells exhibit stem-like characteristics [95] and helps CD133 + CXCR4 + lung cancer stem cells evade immune surveillance [96]. This evidence concerns the gene CD38 and lung carcinoma.